DEVELOPING NEXT GENERATION OF PROGNOSTIC TOOLS FOR LOCALIZED CLEAR CELL RENAL CELL CARCINOMA THROUGH INTEGRATION OF GENOMIC, CLINICAL, AND PATHOLOGICAL FEATURES
$464,261FY2024Defense Health AgencyDOD
The Royal Institution For The Advancement Of Learning